Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial. (2018)
Attributed to:
Adaptive Clinical Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2018-022859
PubMed Identifier: 29743334
Publication URI: http://europepmc.org/abstract/MED/29743334
Type: Journal Article/Review
Volume: 8
Parent Publication: BMJ open
Issue: 5
ISSN: 2044-6055